• ACASA
  • DESPRE NOI
    • INTRODUCERE
    • CONDUCERE
    • COMPANII MEMBRE
    • GRUPURI DE LUCRU
    • DEVINO MEMBRU
    • CINE SUNTEM NOI
  • SUBIECTE CHEIE
  • COD ETIC
    • COD DE CONDUITA ETICA AL APMGR
    • COD DE CONDUITA AL M4E
  • STUDII SI RAPOARTE
  • MASS MEDIA
    • COMUNICATE DE PRESA
    • APMGR IN MASS MEDIA
  • CONTACT
APMGR
  • DESPRE GENERICE
    • DATE GENERALE
    • FAQ’S
    • BROȘURĂ
  • DESPRE BIOSIMILARE
    • Leaflet mediacamente biosimilare
    • Infografice
    • DATE GENERALE
    • NOUTĂȚI
    • FAQ’S
  • EVENIMENTE
    • Conferinta NRI
    • IHF 2017
    • IHF 2015
    • IHF 2013
    • CONFERINTE DE PRESA
      • CONFERINTA DE PRESA 13 IULIE 2017
      • CONFERINTA DE PRESA 3 NOIEMBRIE 2016
      • CONFERINTA DE PRESA 10 FEBRUARIE 2016
      • CONFERINTA DE PRESA 26 NOIEMBRIE 2014
      • CONFERINTA DE PRESA 10 IULIE 2014
    • TOATE EVENIMENTELE
Selectează o Pagină

International Health Forum: APMGR demands the withdrawal of abusive fiscal policies in the pharmaceutical sector

de web@aimee.ro | nov. 29, 2019 | Fără categorie

BUCHAREST, SEPTEMBER 15TH, 2015 – THE ROMANIAN ASSOCIATION OF GENERIC DRUG MANUFACTURERS  (APMGR), representing generic drug manufacturing companies from Romania, demands that authorities withdraw abusive fiscal policies existing in the pharmaceutical field, in...

07.05.2014 – APMGR calls for more transparency in calculating the clawback tax by reporting the number of units settled by CNAS

de web@aimee.ro | nov. 29, 2019 | Fără categorie

THE CLAWBACK TAX ON Q1 2014 CONTINUES TO BE UNREASONABLY HIGH, AS THE PERCENTAGE „P” IN THE CALCULATION OF THE CLAWBACK IS OVER 20% OF THE SALE OF REIMBURSED MEDICINES APMGR REQUIRES THE NATIONAL HEALTH INSURANCE HOUSE (NHIH) TO BE MORE TRANSPARENT IN THE...

09.10.2013 – EGA’s vision of the future for the generic and biosimilar medicine industries in europe

de web@aimee.ro | nov. 29, 2019 | Fără categorie

BRUSSELS, 9 OCTOBER 2013 – On Tuesday 8th October, the European Generic medicines Association (EGA) launched its industrial policy vision for the future of the generic and biosimilar medicine industries in Europe at the EGA Industrial Policy Conference gathering...

01.07.2013 – A new era of biosimilar medicines is about to start: CHMP positive scientific opinion for first biosimilar monoclonal antibodies

de web@aimee.ro | nov. 29, 2019 | Fără categorie

BRUSSELS, 1 July 2013 – The EGA welcomes the European Medicines Agency’s recommendation to the European Commission to approve the first two infliximab biosimilar products, both referenced to Remicade©. “This is a key milestone in the history of medicines in the...

13.06.2013 – Only increased focus on generic and biosimilar medicines can make european healthcare sustainable

de web@aimee.ro | nov. 29, 2019 | Fără categorie

ATHENS, 13 June 2013 – Addressing delegates at the 19th EGA Annual Conference in Athens, Gudbjorg Edda Eggertsdottir stressed that generic and biosimilar medicines companies ensuring high-quality manufacturing jobs and know-how should remain in Europe;...

30.05.2013 – APMGR: A unified clawback tax cannot be a solution to covering the consumption generated by the introduction of new drugs

de web@aimee.ro | nov. 29, 2019 | Fără categorie

Generic medicine producers that do not benefit from the introduction of new molecules on the list, would be severely affected by an unfair tax burden, with serious consequences for patient access to affordable treatment.  The strict criteria introduced by the Ministry...
123»

Articole recente

  • Eforturi susținute pentru asigurarea continuității accesului pacienților români la medicamente, prin plafonarea taxei clawback
  • CNAS a comunicat nivelul taxei clawback pentru trimestrul IV 2019 și anume 27,65%.
  • Guvernul întârzie rezolvarea taxei clawback, o taxă introdusă temporar în anul 2009 și încă prezentă în anul 2020
  • Guvernul întârzie asumarea responsabilității pentru criza medicamentelor generice
  • APMGR este la curent și salută efortul depus de Guvern pentru rezolvarea situației critice în care se află medicamentele generice
apmgr
Politică de confidențialitate
Asociatia Producatorilor de Medicamente Generice din Romania
Calea Floreasca 169 A, Corp A, etaj 4, camera 2003,
sector 1, București, România
Telefon: 0721 266 649
    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok